Carmine Stengone is the founder of Pipeline Therapeutics. Pipeline Therapeutics has raised $110M in total funding. Latest round: Series C.
Carmine Stengone is a biotech executive who was President and CEO of Pipeline Therapeutics, a company that later changed its name to Contineum Therapeutics. He was also noted as a biotech leader and joined the board of directors of Kiora Pharmaceuticals.
Full founder directory · Investor directory · Company funding database · Fundraising library